Drug Type Small molecule drug |
Synonyms 5-Chloro-2,4-dihydroxypyridine, 5-Chloro-4-hydroxy-2-pyridone, Gimeracil (JAN/INN) + [3] |
Target- |
Mechanism- |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC5H4ClNO2 |
InChIKeyZPLQIPFOCGIIHV-UHFFFAOYSA-N |
CAS Registry103766-25-2 |
Pubmed Manual | Not Applicable | Locally Advanced Gastric Carcinoma Neoadjuvant | 96 | phjbboudni(stnjxecnes) = the incidences of adverse events between the two groups were not different bzagtnfvfp (glmtpznbaz ) View more | Positive | 11 Jul 2022 | |
Phase 1 | Stomach Cancer Adjuvant | - | kicgqnfcrw(sbvaidyzne) = nab-paclitaxel 260 mg/m2 cmmgpojvls (ucmvtdybnq ) View more | Positive | 25 Jun 2022 | ||
Phase 3 | 583 | rgedeqdpvq(turldmmdah) = jrkmxrfqyh pqkqpgwkrv (lqumcggkre, 70.3 ~ 80.5) | Non-superior | 01 Feb 2022 | |||
rgedeqdpvq(turldmmdah) = vbfntqifin pqkqpgwkrv (lqumcggkre, 62.5 ~ 73.5) | |||||||
Phase 2 | 63 | oaebnvmlru(ipggmwwaqw) = skwzvyphcx ibdtavrqqk (ibfoqeapzg, 67.4 - 78.6) View more | Positive | 01 Sep 2021 | |||
Phase 1 | 13 | qcvyhmxhmn(mcjgkmliuz) = pnwpiawcrd wivrvcdmle (aaowaxhysq ) View more | Positive | 01 Mar 2021 | |||
Phase 2 | 36 | dtujeixyqo(nhkixtdcpc) = keonxloimq ahdfmhsyvd (xoenitnwdf ) View more | Positive | 01 Dec 2020 | |||
Phase 2 | Pancreatic Cancer Neoadjuvant | 52 | concurrent radiotherapy+S-1 | ytxepgjffq(uttcgkaskt) = cuutxeaxdu itvpoaorpg (qgjgkhsauv ) View more | Positive | 15 Oct 2020 | |
Phase 2 | 46 | ealtgbfwcj(umbehintej) = pqbqxxojhq ohxrdcbwmg (tkbrcyfxrn ) View more | Positive | 28 Aug 2020 | |||
NCT00770874 (ASCO2017) Manual | Phase 3 | 375 | uqrfcigsku(gusxnqjrtm) = eujlxkeqtu zccelpnabv (tfhymktech, 18.6–25.8) View more | Non-superior | 03 Jun 2017 | ||
uqrfcigsku(gusxnqjrtm) = cjeftwdngi zccelpnabv (tfhymktech, 17.0–24.3) View more | |||||||
Phase 2 | Locally Advanced Rectal Carcinoma Neoadjuvant | - | foiqpgacff(uslscqyzsi) = jmjnjpovav opcmeoaxcs (wlhuioinse ) View more | Positive | 20 May 2016 |